logo

Cidara Therapeutics, Inc. (CDTX)



Trade CDTX now with
  Date
  Headline
5/23/2018 6:18:04 AM WBB Securities Ups Cidara Therapeutics, Inc. (CDTX) To Speculative Buy From Hold With $6.25 Price Target
5/21/2018 8:17:04 AM Cidara Therapeutics And Rutgers University Awarded $5.5 Million Grant From NIH
3/19/2018 7:31:25 AM Cidara Therapeutics Reports Positive Topline Results From Phase 2 STRIVE Trial Of Lead Antifungal Rezafungin
8/14/2017 9:24:59 AM Wedbush Is Lowering Cidara Therapeutics, Inc. (CDTX) 2018 Estimate To -2.96 From -2.78
8/14/2017 9:24:39 AM Wedbush Is Lowering Cidara Therapeutics, Inc. (CDTX) 4Q18 Estimate To -0.59 From -0.55
8/14/2017 9:24:19 AM Wedbush Is Cutting Cidara Therapeutics, Inc. (CDTX) 3Q18 Estimate To -0.80 From -0.76
8/14/2017 9:21:07 AM Wedbush Is Cutting Cidara Therapeutics, Inc. (CDTX) 2Q18 Estimate To -0.79 From -0.74
8/14/2017 7:28:20 AM Wedbush Is Lowering Cidara Therapeutics, Inc. (CDTX) 1Q18 Estimate To -0.78 From -0.73
8/14/2017 7:28:00 AM Wedbush Is Lowering Cidara Therapeutics, Inc. (CDTX) 2017 Estimate To -3.63 From -3.39
8/14/2017 7:14:26 AM Wedbush Is Cutting Cidara Therapeutics, Inc. (CDTX) 3Q17 Estimate To -1.01 From -0.91
8/11/2017 8:45:06 AM WBB Securities Ups Cidara Therapeutics, Inc. (CDTX) To Hold From Sell With $6.25 Price Target
7/28/2017 11:49:13 AM WBB Securities Downgrades Cidara Therapeutics, Inc. (CDTX) To Sell From Hold With $6.25 Price Target
5/16/2017 6:51:45 AM Wedbush Reiterates Cidara Therapeutics, Inc. (CDTX) At Outperform With $13.00 Price Target
4/10/2017 5:28:04 PM Wedbush Reiterates Cidara Therapeutics, Inc. (CDTX) At Outperform With $13 Price Target
3/16/2017 9:19:42 AM Wedbush Is Cutting Cidara Therapeutics, Inc. (CDTX) 2017 Estimate To -3.39 From -3.01